Sachin Jain, MD, MBA, has been named as successor to lead CareMore Health System when President Leeba Lessin retires on April 15. Dr Jain is an editorial board member of The American Journal of Managed Care and current chief medical officer of CareMore.
Sachin Jain, MD, MBA, has been named as successor to lead CareMore Health System when President Leeba Lessin retires on April 15. Dr Jain is an editorial board member of The American Journal of Managed Care (AJMC) and current chief medical officer of CareMore. He joined the company in 2015 and his role includes operating responsibility for market performance.
CareMore is a Medicare Advantage insurance plan originating in southern California. It provides care for frail, elderly patients and has developed an integrated patient care delivery system designed to surround patients with care.
“I am honored to be selected to lead CareMore and through my leadership the company will maintain its commitment to innovation, serving the needs of consumers and being a forerunner in value-based health care delivery,” Dr Jain said in a statement.
During his tenure with CareMore, Dr Jain has focused on improving clinical operations, advancing the performance of the clinical and operating teams, and re-invigorating clinical innovation.
Dr Jain was previously chief medical information and innovation officer at Merck, Inc, a lecturer in healthcare policy at Harvard Medical School, an attending physician at the Boston VA Medical Center, special assistant to the national coordinator for health information technology, a senior advisor to CMS, and a member of the faculty at Harvard Business School.
“When I was in public service, I learned of CareMore’s reputation for excellence,” he added. “That’s a tribute to Leeba and her tireless energy and enthusiasm. On behalf of CareMore’s associates, I wish to thank Leeba for her tremendous leadership and mentorship and I look forward to building on her legacy into the future.”
Lessin will remain with the company as a consultant and an instructor for the CareMore Academy.
“I am so proud to have led CareMore during a transformative period when we expanded our model outside of California and then outside of Medicare,” Lessin said in a statement. “It’s been very gratifying to participate in creating a model that has been replicated across the country and has proven effective in improving the lives of so many. In addition, I’m grateful to have had the opportunity to work with a visionary and committed team who strive to be CareMore 100 percent of the time.”
AJMC conducted a Q&A with Dr Jain in 2015, shortly after he joined CareMore. Read the article here.
To learn more about CareMore, read the article that appeared in the June 2015 issue of The American Journal of Accountable Care.
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Covered Preventive Services at Risk: V-BID Summit Breaks Down the Braidwood v Becerra Case
March 20th 2024For more than a decade, certain high-value preventive care services have been covered at no cost to patients under the Affordable Care Act, but a current legal challenge has the coverage at risk.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Most private health insurers have yet to publish criteria for when they will cover postpartum depression drug, zuranolone; state lawmakers are increasingly opposing health care mergers that they believe do not serve the public interest; Medicaid extensions made in 2021 led to a 40% decline in postpartum lack of insurance.
Read More
President Biden will preview his plan to more than double the size of Medicare’s new drug price negotiation program in the upcoming State of the Union address; Mexicans and Central Americans were most affected by the pandemic in terms of all-cause mortality; two Alabama fertility clinics said they expect to resume in vitro fertilization (IVF) services after a bill was passed to protect doctors.
Read More